This suggested that alterations in the TME may have mediated CAR T resistance to GPR65 KO tumors and led to the hypothesis that tumor cells rewired tumor–TME interactions, leading to the local ineffectiveness of CAR T cells. Here, GPR65 is linked to neoplasm.